A comparison of pancreaticoduodenectomy with extended pancreaticoduodenectomy: A meta-analysis of 1909 patients

European Journal of Surgical Oncology

Volumn 35, Issue 1, 2009, Pages 79-86

  Iqbal, N ^a   Lovegrove, R E ^b   Tilney, H S ^b   Abraham, A T ^a   Bhattacharya, S ^a   Tekkis, P P ^b   Kocher, H M ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Complications; Lymph node; Pancreatic carcinoma; Resection margins; Survival

Indexed keywords

ARTICLE; CLINICAL TRIAL; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE; META ANALYSIS; OPERATION DURATION; PANCREATICODUODENECTOMY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STOMACH EMPTYING; SURGICAL MORTALITY; SURVIVAL TIME; SYSTEMATIC REVIEW; TUMOR VOLUME;

HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; RISK FACTORS; SURVIVAL RATE;

EID: 57549115412     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.01.002     Document Type: Article

References (50)

1. O'Sullivan A., and Kocher H.M. Pancreatic cancer. BMJ Clin Evid 11 (2007) 409-436. http://clinicalevidence.bmj.com/ceweb/conditions/dsd/0409/0409_contribdetails.jsp http://clinicalevidence.bmj.com/ceweb/conditions/dsd/0409/0409_contribdetails.jsp
2. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350 12 (2004) 1200-1210
3. Fortner J.G. Regional resection of cancer of the pancreas: a new surgical approach. Surgery 73 2 (1973) 307-320
4. Ishikawa O., Ohhigashi H., Sasaki Y., et al. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 208 2 (1988) 215-220
5. Manabe T., Ohshio G., Baba N., et al. Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer 64 5 (1989) 1132-1137
6. Satake K., Nishiwaki H., Yokomatsu H., et al. Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet 175 3 (1992) 259-265
7. Naganuma T., Isaji S., and Kawarada Y. Staging and extended resection for pancreatic cancer. Pancreas 16 3 (1998) 355-362
8. Nakao A., Harada A., Nonami T., Kaneko T., Inoue S., and Takagi H. Clinical significance of portal invasion by pancreatic head carcinoma. Surgery 117 1 (1995) 50-55
9. Mukaiya M., Hirata K., Satoh T., et al. Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas: retrospective multi-institutional analysis in Japan. World J Surg 22 3 (1998) 248-252
10. Miyzaki I., and Nagakawa T. Extended lymphadenectomy in pancreatic resection for cancer (1998), Williams & Wilkins, Baltimore
11. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236 3 (2002) 355-366
12. Farnell M.B., Pearson R.K., Sarr M.G., et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 138 4 (2005) 618-628
13. Pedrazzoli S., DiCarlo V., Dionigi R., et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228 4 (1998) 508-517
14. Henne-Bruns D., Vogel I., Luttges J., Kloppel G., and Kremer B. Ductal adenocarcinoma of the pancreas head: survival after regional versus extended lymphadenectomy. Hepatogastroenterology 45 21 (1998) 855-866
15. Michalski C.W., Kleeff J., Wente M.N., Diener M.K., Buchler M.W., and Friess H. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 94 3 (2007) 265-273
16. Clarke M., and Horton R. Bringing it all together: Lancet-Cochrane collaborate on systematic reviews. Lancet 357 9270 (2001) 1728
17. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283 15 (2000) 2008-2012
18. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 7109 (1997) 629-634
19. Haldane J.B. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20 4 (1956) 309-311
20. Mantel N., and Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22 4 (1959) 719-748
21. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 3 (1986) 177-188
22. Sterne J.A., and Davey Smith G. Sifting the evidence-what's wrong with significance tests?. BMJ 322 7280 (2001) 226-231
23. Parmar M.K., Torri V., and Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17 24 (1998) 2815-2834
24. Athanasiou T., Al-Ruzzeh S., Kumar P., et al. Off-pump myocardial revascularization is associated with less incidence of stroke in elderly patients. Ann Thorac Surg 77 2 (2004) 745-753
25. Capussotti L., Massucco P., Ribero D., Vigano L., Muratore A., and Calgaro M. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg 138 12 (2003) 1316-1322
26. Gazzaniga G.M., Cappato S., Papadia F., Mori L., and Filauro M. D1 versus D2 pancreatoduodenectomy in surgical therapy of pancreatic head cancer. Hepatogastroenterology 48 41 (2001) 1471-1478
27. Henne-Bruns D., Kremer B., Meyer-Pannwitt U., Vogel I., and Schroder S. Partial duodenopancreatectomy with radical lymphadenectomy in patients with pancreatic and periampullary carcinomas: initial results. Hepatogastroenterology 40 2 (1993) 145-149
28. Henne-Bruns D., Vogel I., Luttges J., Kloppel G., and Kremer B. Surgery for ductal adenocarcinoma of the pancreatic head: staging, complications, and survival after regional versus extended lymphadenectomy. World J Surg 24 5 (2000) 595-601
29. Iacono C., Accordini S., Bortolasi L., et al. Results of pancreaticoduodenectomy for pancreatic cancer: extended versus standard procedure. World J Surg 26 11 (2002) 1309-1314
30. Iacono C., Bortolasi L., Facci E., et al. Does extended pancreaticoduodenectomy increase operative morbidity and mortality vs. standard pancreaticoduodenectomy?. J Gastrointest Surg 1 5 (1997) 446-453
31. Kremer B., Vogel I., Luttges J., Kloppel G., and Henne-Bruns D. Surgical possibilities for pancreatic cancer: extended resection. Ann Oncol 10 Suppl 4 (1999) S252-S256
32. Nguyen T.C., Sohn T.A., Cameron J.L., et al. Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg 7 1 (2003) 1-9
33. Popiela T., Kedra B., and Sierzega M. Does extended lymphadenectomy improve survival of pancreatic cancer patients?. Acta Chir Belg 102 2 (2002) 78-82
34. Riall T.S., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma - part 3: update on 5-year survival. J Gastrointest Surg 9 9 (2005) 1191-1206
35. Yang Y.-m., Wan Y.-l., Tian X.-d., Zhuang Y., and Huang Y.-t. Outcome of pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for adenocarcinoma of the head of the pancreas. Chin Med J 118 22 (2005) 1863-1869
36. Yeo C.J., Cameron J.L., Sohn T.A., et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 229 5 (1999) 613-622
37. McCulloch P., Nita M.E., Kazi H., and Gama-Rodrigues J. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 4 (2004) CD001964
38. Singh Ranger G., and Mokbel K. The evolving role of sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol 29 5 (2003) 423-425
39. Crowe P., and Temple W. Management of the axilla in early breast cancer: is it time to change tack?. Aust N Z J Surg 70 4 (2000) 288-296
40. Cserni G., Gregori D., Merletti F., et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 91 10 (2004) 1245-1252
41. Kim T., Giuliano A.E., and Lyman G.H. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106 1 (2006) 4-16
42. Kocher H.M., Sohail M., Benjamin I.S., and Patel A.G. Technical limitations of lymph node mapping in pancreatic cancer. Eur J Surg Oncol 33 7 (2007) 887-891
43. Iqbal N, Lovegrove RE, Tilney HS, et al. A comparison of pancreaticoduodenectomy with pylorus preserving pancreaticoduodenectomy: a meta-analysis of 2822 patients. Eur J Surg Oncol 2008, in this issue.
44. van Berge Henegouwen M.I., van Gulik T.M., DeWit L.T., et al. Delayed gastric emptying after standard pancreaticoduodenectomy versus pylorus-preserving pancreaticoduodenectomy: an analysis of 200 consecutive patients. J Am Coll Surg 185 4 (1997) 373-379
45. Schniewind B., Bestmann B., Henne-Bruns D., Faendrich F., Kremer B., and Kuechler T. Quality of life after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head. Br J Surg 93 9 (2006) 1099-1107
46. Stocken D.D., Buchler M.W., Dervenis C., et al. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 92 8 (2005) 1372-1381
47. Knaebel H.P., Marten A., Schmidt J., et al. Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma - CapRI: study protocol (ISRCTN62866759). BMC Cancer 5 1 (2005) 37
48. Garcea G., Dennison A.R., Ong S.L., et al. Tumour characteristics predictive of survival following resection for ductal adenocarcinoma of the head of pancreas. Eur J Surg Oncol 33 7 (2007) 892-897
49. Kleeff J., Michalski C.W., Friess H., and Buchler M.W. Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies. Eur J Surg Oncol 33 7 (2007) 817-823
50. Pedrazzoli S., Beger H.G., Obertop H., et al. A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg 16 4 (1999) 337-345